A poly-omics machine-learning method to predict metabolite production in CHO cells by Zampieri, Guido et al.
  
The 2nd International Electronic Conference on Metabolomics (IECM-2), 20 November–27 November 2017; Sciforum 
Electronic Conference Series, Vol. 2, 2017 
Conference Proceedings Paper 
A poly-omics machine learning method to predict 
metabolite production in CHO cells 
Guido Zampieri1, Macauley Coggins2, Giorgio Valle1 and Claudio Angione2,* 
1 CRIBI Biotechnology Centre, University of Padova, viale G. Colombo 3, 35131 Padova, Italy; 
guido.zampieri@phd.unipd.it 
2 Department of Computer Science and Information Systems, Teesside University, Borough road, TS1 3BA 
Middlesbrough, UK; c.angione@tees.ac.uk 
* Correspondence: c.angione@tees.ac.uk; Tel.: +4401642342681 
Academic Editor: name 
Published: date 
Abstract: The success of biopharmaceuticals as highly effective clinical drugs has 
recently led industrial biotechnology towards their large-scale production. The 
ovary cells of the Chinese hamster (CHO cells) are one of the most common 
production cell line. However, they are very inefficient in producing desired 
compounds. This limitation can be tackled by culture bioengineering, but 
identifying the optimal interventions is usually expensive and time-consuming. In 
this study, we combined machine learning techniques with metabolic modelling 
to estimate lactate production in CHO cell cultures. We trained our poly-omics 
method using gene expression data from varying conditions and associated 
reaction rates in metabolic pathways, reconstructed in silico. The poly-omics 
reconstruction is performed by generating a set of condition-specific metabolic 
models, specifically optimised for lactate export estimation. To validate our 
approach, we compared predicted lactate production with experimentally 
measured yields in a cross-validation setting. Importantly, we observe that 
integration of metabolic predictions significantly improves the predictive ability 
of our machine learning pipeline when compared to the same pipeline based on 
gene expression alone. Our results suggest that, compared to transcriptomic-only 
studies, combining metabolic modelling with data-driven methods vastly 
improves the automatisation of cultures design, by accurately identifying optimal 
growth conditions for producing target therapeutic compounds. 
Keywords: CHO cell; Biopharmaceutical; Metabolic modelling; Machine learning; 
Flux balance analysis.   
 
1. Introduction 
Chinese hamster ovary (CHO) cells are widely regarded as one of the most reliable 
cell types for industrial-scale mammalian protein production. As compared to 
bacterial cell lines such as those of Escherichia coli, CHO cultured cells are less 
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productive, much fragile and grow slowly. In turn, this means that the 
manufacturing methods that facilitate protein production using CHO cell lines are 
much more expensive and time-consuming. However, heavy interest is put in 
optimising CHO cell lines as they are required to produce mammalian 
recombinant proteins. 
Recent advances in this context have focused on unraveling the complex 
biological machinery controlling desirable characteristics of protein synthesis and 
secretion [1]. While gene expression profiling has proved helpful in past studies, 
there have been recent efforts to combine genetic data with knowledge of 
metabolic pathways through the reconstruction of genome-scale metabolic models 
(GSMMs). GSMMs attempt to describe cellular metabolism in silico through gene 
annotation and stoichiometry associated with reactions and metabolites, as well as 
with constraints such as upper or lower bounding of metabolic flux rates. Flux 
balance analysis (FBA) allows to predict the configuration of metabolic reaction 
fluxes within GSMMs under general growth conditions [2]. Condition-specific 
GSMMs can be built using a variety of methods and extended FBA pipelines. The 
idea is to use omic-data available in each condition, and a set of rules to constrain 
the flux rates of the general-purpose GSMM [20,21]. 
Metabolic models have recently been reconstructed for CHO-K1, CHO-S, and 
CHO-DG44 cell lines, along with a general consensus model [3].  These models 
were useful in quantifying the protein synthesis capacity of these cell lines and 
revealed that bioprocessing treatments such as histone deacetylase inhibitors' lead 
to an inefficiency in increasing product yield. FBA can thus reveal the impact of 
various media and culture conditions on growth and yield of cultured cells, aiding 
CHO cells bioengineering [3-6]. Moreover, computational estimation of metabolic 
fluxes can be an asset when experimental data is not available [7]. 
However, the precision of GSMMs strongly depends on available pathway and 
biochemical knowledge. Especially when dealing with the complexity of 
mammalian cells, more advanced computational techniques may be necessary for 
an effective application to real problems within the bio-processing industry. In 
particular, machine learning coupled with computational modelling of CHO cells 
has the potential to effectively elucidate optimal bioengineering steps towards 
improved production of therapeutic metabolites and proteins [8]. 
Here we present a new approach integrating machine learning and metabolic 
modelling for the computational prediction of protein production in CHO cells. We 
propose to integrate experimental data on the gene level with data generated in 
silico via a GSMM of CHO cells metabolism within an integrated data-driven 
framework (Figure 1). We evaluated this approach by a computational validation, 
estimating the average prediction error in general settings. Importantly, we 
observe that metabolic predictions coupled with gene expression data can 
significantly improve estimations of lactate production based solely on gene 
expression. 
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 Figure 1. Workflow of the proposed approach for the prediction of metabolite and protein prediction in 
CHO cells. Steps (i)-(iv) are presented in the Methods section of this work. They serve the final goal of 
optimising culture bioengineering, depicted in step (v). Integrating transcriptomics data, machine learning 
methods and metabolic modelling improves the predictive ability of transcriptomic-only methods. 
2. Materials and Methods  
2.1 Publicly available gene expression data  
As a first data source, a large-scale gene expression dataset from two different 
CHO cell lines was used [9]. This dataset contains 295 microarray profiles with 
expression values for 3592 genes from 121 CHO cell cultures of varying conditions 
in terms of including cell density, growth rate, viability, lactate and ammonium 
accumulation and cell productivity. We extracted the 127 profiles with available 
quantification of lactate accumulation. 
2.2 Genome scale reconstruction of CHO metabolism  
We used a recently developed GSMM of CHO cell metabolism, previously 
used to accurately predict growth phenotypes [3]. This model is the largest 
reconstruction of CHO metabolism to date, with 1766 genes and 6663 reactions, 
aggregating community knowledge from various sources.  Being a consensus 
model, it provides general mechanistic relationships that can be refined depending 
on the particular task or cell line of interest. 
2.3 Building condition-specific poly-omics models of CHO cells 
To create condition and cell line-specific poly-omics models the genome-scale 
model of CHO cell metabolism was combined with the gene expression data from 
CHO cell cultures in varying conditions. In this step, data accessible via the BIGG 
(i) Transcriptional profiles from a 
range of culture conditions
(ii) Condition-specific poly-omic models of 
metabolism and its genetic regulation
(iv) Machine learning to predict metabolite/protein 
production in untested conditions
(iii) Computational metabolic 
analysis for model fine-tuning
(v) Optimisation of  
bioengineering of cultured cells
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repository was employed to match gene identifiers [10]. A model for each 
condition was created by computing gene set effective expressions Θ for each 
reaction, following previous investigations [11,12]. The effective expression at 
reaction level is thereby determined by gene expressions θ(g) and by gene-protein-
reaction rules, properly converted to min/max rules depending on the type of gene 
set. In particular, we define Θ(g) = θ(g) for single genes, Θ(g1 ∧ g2) = min{θ(g1), 
θ(g2)} for enzymatic complexes and Θ(g1 ∨ g2) = max{θ(g1), θ(g2)} for isozymes. 
Lower bounds and upper bounds for each reaction were obtained by applying the 
following multiplicative coefficient to its native bounds:  
ϕ(Θ) = [1 + γ|log(Θ)|]sgn(Θ-1), (1) 
where γ is a parameter controlling the impact of gene expression on reaction 
bounds. 
2.4 Extraction of metabolic features 
 After a model for each condition was created, flux distributions were 
computed using FBA by maximising the biomass for producing cell lines included 
in the CHO model [3]. To perform FBA we employed the COBRA toolbox and a 
multi-level linear program structure [13,24]. All simulations were carried out in 
Matlab R2014b with the Gurobi solver. 
2.5 Feature processing and selection 
Principle Component Analysis (PCA) is a very effective statistical tool that uses 
an orthogonal transformation to reduce a set of variables to a smaller set of linearly 
uncorrelated variables, known as the principle components [14]. Here PCA was 
used to process metabolic flux features in order to extract informative metabolic 
features. 
Moreover, elastic net was applied to select relevant features, both at a gene 
expression and metabolic level [15]. Given an α in the interval ]0, 1] and a non-
negative λ, elastic net solves the following optimisation problem: 
𝑚𝑖𝑛𝛽0,𝛽 (
1
2𝑁
∑ (𝑦𝑖 − 𝛽0 − 𝑥𝑖
𝑇𝛽)2𝑁𝑖=1 + 𝜆𝑃𝛼(𝛽)). (2) 
In this formula, x represents the gene expression and metabolic flux rates variables, 
y corresponds to measured metabolite yield and N is the total number of training 
conditions. Pα(β) is a regularisation term depending on a vector of linear 
coefficients β and on parameter α. Non-null entries of β resulting from this 
minimisation correspond to relevant features selected by elastic net. 
2.6 Training generalised linear models to predict metabolite/protein production 
Generalised linear models (GLM) were trained to predict lactate yield starting 
from poly-omics information [16]. A GLM gives an estimate of metabolite 
production yipred calculated as follows: 
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𝑦𝑖
𝑝𝑟𝑒𝑑 = 𝛽0 + 𝑥𝑖
𝑇𝛽. (3) 
 GLM accuracy was assessed by nested cross-validation, consisting of two 
cross-validation loops which together evaluate a selected model based on training 
data [17]. The nested loop selects the values of α and λ of elastic net on 5 training 
and test folds. The outer loop is used for model evaluation and is ran over 10 folds. 
GLM accuracy for each test fold was evaluated by computing the root-mean-
square error (RMSE) defined by the following formula:  
RMSE =√
∑ (𝑦
𝑖
𝑝𝑟𝑒𝑑
−𝑦𝑖)
2
𝑛
𝑖=1
𝑛
, (4) 
where n is the number of test conditions in the fold. 
3. Results 
3.1. Metabolic model optimisation 
We validated our proposed approach on the prediction of lactate production, 
resorting to experimental data from the study of Clarke et al. [9]. We selected the 
conditions with both microarray and measured lactate production, obtaining 127 
conditions. In order to optimise metabolic flux information, we performed a 
sensitivity analysis on the gene expression mapping parameter γ in Equation (1). 
Specifically, we studied the Pearson correlation r between measured lactate 
accumulation in culture media and simulated lactate export rates for varying 
values of γ across several orders of magnitude. The maximum correlation 
coefficient obtained was r = 0.36 (p-value = 2.6·10-5). The relationships between 
these two quantities can be visualised in Figure 2a. We thus employed condition-
specific models with the optimal γ to generate fluxes for the following analysis. 
 
(a) (b) 
 Figure 2. Validation results of the proposed approach on lactate production prediction: (a) comparison 
between simulated lactate export through condition-specific GSMMs and measured lactate production; this 
step enables GSMMs optimisation for the target metabolite in the following step; (b) RMSE distribution plots 
for lactate production predictions as a function of employed data sources. Two outliers for the green box lie 
outside of the current scale. 
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3.2 Predictions of lactate production 
 To accurately predict lactate production in CHO cells, we employed elastic net 
and GLMs as described in the Methods section. We estimated the generalised 
prediction error by means of a 10-fold cross-validation, repeatedly swapping 
conditions used in training and in tests [17]. We calculated the RMSE of predicted 
lactate yield across the test conditions in each fold, which quantifies the average 
difference between predicted and experimentally measured lactate yield. We 
repeated this procedure under three data sources scenarios, where gene 
expression, metabolic fluxes and their combination was evaluated separately. The 
results are shown in Figure 2b and summarised in Table 1. Interestingly, although 
flux rates alone lead to poor predictions, if combined with gene expression they 
achieve the minor average and median RMSE across the 10 folds. In the latter case, 
associated RMSE distribution is significantly different to that obtained from gene 
expression alone on the basis of a one-tailed Wilcoxon rank sum test at a 5% 
threshold (p-value = 0.027) [18]. 
 
 Gene expression Flux rates 
Gene expression and 
flux rates 
Mean RMSE 0.19 1.08 0.14 
Median RMSE 0.17 0.26 0.13 
RMSE standard  
deviation 
0.06 2.41 0.05 
 
Table 1. Comparison of 10-fold cross-validation RMSE statistics for the prediction of lactate production from 
different data sources. Combining gene expression and metabolic flux data leads to best values for all 
statistical measures. These results correspond to those shown in Figure 2b. 
 
4. Discussion 
The growing demand for natural products in global healthcare requires 
advanced automation of CHO cell culture design for biotechnological industry to 
reach commercial-scale production levels. Notably, recent advances in metabolic 
modelling and in data-driven prediction algorithms have not been yet exploited in 
combination for this purpose. In this study, we started to explore this research line: 
the overall goal of the work was to develop a poly-omics approach capable of 
predicting metabolite/protein production in CHO cells. The approach comprises a 
GLM trained on gene expression data originating from cultures in varying 
conditions and on metabolic flux rates obtained in silico from FBA on a GSMM of 
CHO metabolism. The accuracy of our approach was evaluated in comparison to 
GLMs employing only a single type of data. This allowed us to show that 
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combining gene expression and metabolic fluxes improves accuracy compared to 
just using gene expression or metabolic fluxes separately.  
Generation of condition-specific metabolic information can in principle be 
achieved through various types of computational analysis. In this study, we used 
FBA as this is the most widely used technique to capture flux configurations in a 
growth steady state [2]. In principle, different techniques could potentially extract 
even more useful information, further improving final data-driven predictions. For 
instance, in a preliminary evaluation we tested also a modified version of 
parsimonious enzyme usage FBA minimising the norm-2 of reaction fluxes [22,23]. 
However, we observed that normal FBA achieved best results (data not shown). 
The main limitation of this work is represented by a scarce availability of large-
scale public data on CHO cells and by the prototypical state of present GSMMs. 
Proposed strategies for model refining are expected to lead to further prediction 
improvements [19].  With more comprehensive datasets, both in terms of number 
of samples and in terms of metabolic gene coverage, we expect our pipeline to 
vastly improve its predictive ability. Moreover, although our validation focussed 
on lactate production, the proposed methodological framework can be 
straightforwardly implemented around any target metabolite or protein.  
Despite the above-mentioned limitations, our results show that metabolism-
based machine learning methods can significantly improve the predictive power of 
common transcriptomic-only methods. This is due to the introduction of metabolic 
features coupled with transcriptomic features. The present study therefore 
represents a preliminary assessment that we plan to extend in future 
investigations. 
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